Publications by authors named "Gabriele Kaltenecker"

Claim this Profile
H
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registry.
Marc Thill, Mark-Oliver Zahn, Anja Welt, Arnd Nusch, Matthias Zaiss, Gabriele Kaltenecker

Int J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study.
Steffi Hartmann, Maggie Banys-Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Davide Gentilini, Gabriele Kaltenecker

Breast Cancer Res Treat· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Sherko Kuemmel, Joerg Heil, Anna Rueland, Christine Seiberling, Hakima Harrach, Gabriele Kaltenecker

Ann Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA study.
Steffi Hartmann, Thorsten Kühn, Michael Hauptmann, Elmar Stickeler, Marc Thill, Gabriele Kaltenecker

Geburtshilfe Frauenheilkd· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
Rachel Wuerstlein, Nadia Harbeck, Eva-Maria Grischke, Dirk Forstmeyer, Raquel von Schumann, Gabriele Kaltenecker

Breast Care (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treosulfan in the Treatment of Advanced Ovarian Cancer - Results of a German Multicenter Non-interventional Study.
Radoslav Chekerov, Gabriele Kaltenecker, Dietmar Reichert, Thomas Göhler, Peter Klare

Anticancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
Silvia Darb-Esfahani, Gunter von Minckwitz, Carsten Denkert, Beyhan Ataseven, Bernhard Högel, Gabriele Kaltenecker

BMC Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis